Quantum computing remains one of the more closely watched speculative themes in the market, and QUBT (Quantum Computing Inc.) along with RGTI (Rigetti Computing) sit squarely in that discussion. This comparison looks at how two small-cap names—one centered on integrated photonics and the other on superconducting qubits—compare in the current environment. The analysis matters most for growth-oriented traders and longer-term investors comfortable with volatility who are weighing relative performance, positioning, and catalysts instead of near-term earnings. Since both remain pre-profit and heavily influenced by sentiment, understanding their distinct models and momentum is key.
QUBT (Quantum Computing Inc.) operates in quantum optics and integrated photonics from its base in Hoboken, New Jersey. The focus is on room-temperature, low-power photonic systems such as the Dirac-3 quantum optimization machine and NeuraWave photonic reservoir computing platform, plus foundry services for thin-film lithium niobate chips. I checked recent developments using Tickeron’s AI Pattern Search Engine to confirm activity around its expansion. The company has moved quickly on acquisitions, including Luminar Semiconductor, NuCrypt, and NHanced Semiconductors, to build U.S. manufacturing capacity. Those steps helped revenue rise to roughly $5.6 million in the most recent quarter from minimal levels a year earlier, with a contract backlog near $42.5 million. Cash on hand exceeds $1 billion. Even so, the shares have given back ground in recent weeks amid broader quantum-sector cooling and sit well below 52-week highs.
RGTI (Rigetti Computing) is a full-stack quantum-computing firm based in Berkeley, California, built around superconducting qubit systems. It designs and makes its own chips and sells on-premises systems such as the 9-qubit Novera QPU and 108-qubit Cepheus-1-108Q, while also providing access via Rigetti Quantum Cloud Services. A notable recent step was a definitive agreement for a $100 million CHIPS Act award from the U.S. Department of Commerce to support superconducting quantum R&D, with a minority government equity stake. Revenue has increased from Novera deliveries and government-related work, reaching about $5.1 million in the latest quarter, though operating losses remain sizable. Cash exceeds $500 million with no debt. Shares have declined notably in recent months as investors remain cautious on the path to larger commercial revenue.
The main technological difference stands out clearly. RGTI competes in vertically integrated superconducting hardware for gate-based systems, while QUBT emphasizes room-temperature photonics and optimization-focused platforms. Growth drivers also vary: QUBT has relied on acquisitions and manufacturing scale, whereas RGTI centers on system deliveries, government programs, and progress toward higher-fidelity systems. Recent momentum has softened for both amid sector de-risking, though QUBT has generally seen a shallower year-to-date drawdown than RGTI. Risks differ as well—QUBT faces integration challenges from rapid M&A activity, while RGTI carries concentration around government funding and a smaller revenue base relative to valuation. Both remain sensitive to macro sentiment affecting high-multiple, pre-profit tech names. I also reviewed sector positioning through Tickeron’s AI Trend Prediction Engine for additional context on relative stability.
Based on factors such as trend consistency, relative stability, catalyst quality, and market positioning, the assessment leans toward QUBT at this point. The shallower year-to-date drawdown, larger cash cushion, and diversified revenue paths through photonics and manufacturing provide a somewhat steadier profile than RGTI, which depends more heavily on government funding and carries a smaller revenue base. This view is probabilistic, however, and could shift if RGTI’s CHIPS Act catalyst gains traction or new data alters the picture.
In my ongoing research on volatile names like these, I often review Tickeron’s AI Trading Bots to see how different automated approaches are positioned across market conditions. The platform helps surface strategies aligned with current trends, offering an extra data point alongside traditional analysis without replacing it. This adds perspective on momentum signals for investors evaluating names such as QUBT and RGTI.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
QUBT saw its Momentum Indicator move below the 0 level on October 01, 2026. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 81 similar instances where the indicator turned negative. In 76 of the 81 cases, the stock moved further down in the following days. The odds of a decline are at 90%.
The Moving Average Convergence Divergence Histogram (MACD) for QUBT turned negative on October 01, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 47 similar instances when the indicator turned negative. In 43 of the 47 cases the stock turned lower in the days that followed. This puts the odds of success at 90%.
QUBT moved below its 50-day moving average on October 01, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for QUBT crossed bearishly below the 50-day moving average on October 07, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 17 of 18 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 90%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where QUBT declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 87%.
The Aroon Indicator for QUBT entered a downward trend on October 23, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where QUBT's RSI Oscillator exited the oversold zone, 22 of 25 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 88%.
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 58 of 65 cases where QUBT's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 89%.
Following a +6.23% 3-day Advance, the price is estimated to grow further. Considering data from situations where QUBT advanced for three days, in 196 of 227 cases, the price rose further within the following month. The odds of a continued upward trend are 86%.
QUBT may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Tickeron Valuation Rating of 7 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.933) is normal, around the industry mean (-7.861). QUBT's P/E Ratio (-164.000) is considerably lower than the industry average of (-3.305). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (23.994). Dividend Yield (0.000) settles around the average of (0.011) among similar stocks. P/S Ratio (169.492) is also within normal values, averaging (51.774).
The Tickeron PE Growth Rating for this company is 23 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Seasonality Score of 34 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Price Growth Rating for this company is 83 (best 1 - 100 worst), indicating slightly worse than average price growth. QUBT’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 91 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. QUBT’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 88, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Industry ComputerProcessingHardware